Michael V. Lukens
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 20, 2026
Major reduction in occurrence of anti-c and anti-E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c-matching.
Journal: British journal of haematology
Published: July 11, 2024
Use and Waste of Reconstituted Whole Blood Exchange Transfusions: An 11-year National Observational Study.
Journal: The Journal of pediatrics
Published: June 06, 2024
Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study.
Journal: Thrombosis research
Published: November 23, 2023
Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 31, 2023
Fluctuations in Thyroid Hormone Levels During Initial Treatment for Differentiated Thyroid Carcinoma are Associated with Changes in Hemostasis: A Prospective Cohort Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: November 02, 2022
TEMPORARY REMOVAL: Direct oral anticoagulants in antithrombin deficiency: initial experience in a single center.
Journal: Thrombosis and haemostasis
Published: September 27, 2022
Anti-IFC antibodies in a patient with CHAPLE syndrome: Implications for blood management.
Journal: British journal of haematology
Published: August 19, 2022
Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels.
Journal: Clinical pharmacokinetics
Published: July 22, 2022
Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury.
Journal: Scientific reports
Published: April 08, 2022
Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories.
Journal: International journal of laboratory hematology
Published: May 17, 2021
Last Updated: 09/26/2026